Advertisement
EMR vs IR
Which Stock Would AI Choose? Emerson Electric (EMR) vs. Ingersoll Rand (IR) Stock Comparison
Key Takeaways
- EMR is a global automation and software leader, while IR is a diversified maker of mission-critical air, fluid, and life sciences technologies.
- Emerson has shown stronger recent momentum, with double-digit returns over the trailing 90 days, while Ingersoll Rand's share price has been more range-bound.
- Both companies beat earnings expectations in their most recent quarters and raised full-year guidance, signaling resilient industrial demand.
- Emerson leans on higher-margin software and power/semiconductor exposure, whereas Ingersoll Rand relies on an acquisitive, bolt-on growth model.
- Valuations diverge sharply, with Ingersoll Rand trading at a premium multiple relative to Emerson.
Introduction
Investors scanning the industrial sector frequently encounter two names that sit at the intersection of manufacturing and technology: EMR (Emerson Electric) and IR (Ingersoll Rand). Although both operate in the broader industrial machinery space, their business models, growth drivers, and market positioning differ meaningfully. This stock comparison is relevant for traders and long-term investors seeking to understand relative performance, sentiment shifts, and which company may be better suited to the current market environment. By examining recent results, momentum, sector exposure, and valuation, readers can form a clearer picture of how these two equities stack up against one another.
EMR Overview and Recent Performance
Emerson Electric is a St. Louis-based global automation and software company that helps customers optimize industrial operations. The company operates through segments including Software & Systems, Intelligent Devices, and Safety & Productivity, with growing exposure to power generation, semiconductors, and data-center automation.
Recent market activity has favored EMR. The stock has posted a strong year-to-date advance, with gains accelerating in recent weeks as investors rewarded the company's software-led strategy and its push into AI-enabled automation. Emerson's most recent quarterly results beat expectations, with adjusted earnings per share (EPS) rising double digits and underlying orders growing solidly. Management raised its full-year outlook for sales, earnings, and free cash flow, citing resilient demand across power, life sciences, and liquefied natural gas (LNG) end markets. Annual contract value in its software portfolio also expanded, reinforcing a recurring-revenue narrative that has helped lift sentiment.
IR Overview and Recent Performance
Ingersoll Rand is a diversified industrial company providing mission-critical air compression, vacuum, blower, fluid transfer, and life sciences solutions under more than 80 brands. It operates through two primary segments: Industrial Technologies & Services and Precision & Science Technologies.
In recent weeks, IR has delivered steady, if less spectacular, performance. The company reported revenue and adjusted EPS that exceeded consensus estimates, supported by acquisitions and favorable currency effects, while organic growth remained modest. Orders strengthened sequentially, and management raised its full-year revenue guidance. However, the stock's relative performance has lagged, with shares trading well below their 52-week high and a more muted one-year return than Emerson. Ingersoll Rand's growth continues to lean heavily on mergers and acquisitions (M&A), with a large deal funnel and disciplined bolt-on strategy, alongside a growing aftermarket and service revenue base.
Trending AI Robots
For traders who prefer a data-driven, automated approach, Tickeron's Trending AI Robots page offers a curated view of the platform's most relevant AI trading bots. Tickeron hosts hundreds of AI Trading Bots that collectively trade thousands of different tickers, each with its own trading style, strategy, timeframe, performance record, and set of covered stocks. Because not every bot fits every market condition, only the best-performing and most suitable bots for the current environment are featured in this Trending AI Robots section. The page highlights measurable statistics so visitors can evaluate each bot's track record at a glance. Exploring the Trending AI Robots list is a practical way to see how algorithmic strategies are positioning across names like EMR and IR.
Head-to-Head Comparison
From a business-model perspective, the two companies differ in focus. EMR has repositioned itself as an automation and software leader, with a higher-margin, technology-centric portfolio tied to electrification, semiconductors, and AI infrastructure. IR remains more hardware-centric, emphasizing flow creation and compression equipment, with growth augmented through frequent bolt-on acquisitions and an expanding service mix.
On momentum, Emerson holds the edge. Its share price has delivered stronger trailing returns and benefits from clearer secular catalysts, including data-center power demand and test-and-measurement strength. Ingersoll Rand's price action has been comparatively range-bound, even as its fundamentals improve, suggesting more muted investor enthusiasm in the near term.
Risk profiles also diverge. Emerson carries geographic exposure to Europe and China, where demand has softened, and is navigating Middle East disruptions. Ingersoll Rand faces margin pressure from inflation, particularly in China, and depends on deal execution to sustain growth. On valuation, Ingersoll Rand trades at a notably higher price-to-earnings multiple than Emerson, reflecting a premium that may already discount its growth strategy.
Tickeron AI Verdict
Based on observable factors such as trend consistency, catalyst visibility, and relative positioning, Tickeron's AI would likely favor EMR in the current environment. Emerson exhibits stronger and more consistent recent momentum, a higher-margin software-led model, and multiple secular demand drivers that support its outlook. Ingersoll Rand presents a solid operational story, but its comparatively muted price trend, heavier reliance on M&A, and premium valuation introduce greater uncertainty. This assessment is probabilistic rather than definitive: relative positioning can shift quickly as new earnings data and macroeconomic conditions emerge, and both stocks carry distinct risks that warrant ongoing monitoring.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EMR is a StrongBuy and IR is a Hold.
EMR in upward trend: 10-day moving average crossed above 50-day moving average on September 29, 2026
The 10-day moving average for EMR crossed bullishly above the 50-day moving average on September 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 71%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on EMR as a result. In 62 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 68%.
The Moving Average Convergence Divergence (MACD) for EMR just turned positive on October 27, 2026. Looking at past instances where EMR's MACD turned positive, the stock continued to rise in 30 of 44 cases over the following month. The odds of a continued upward trend are 68%.
Following a +2.69% 3-day Advance, the price is estimated to grow further. Considering data from situations where EMR advanced for three days, in 217 of 345 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
The Aroon Indicator entered an Uptrend today. In 150 of 274 cases where EMR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 55%.
Bearish Trend Analysis
The 10-day RSI Indicator for EMR moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In 17 of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at 40%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EMR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.
EMR broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of 14 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 16 (best 1 - 100 worst), indicating outstanding price growth. EMR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 18 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 38 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 62 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 81 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.673) is normal, around the industry mean (4.242). P/E Ratio (37.198) is within average values for comparable stocks, (38.374). Projected Growth (PEG Ratio) (1.837) is also within normal values, averaging (1.879). Dividend Yield (0.013) settles around the average of (0.030) among similar stocks. P/S Ratio (4.409) is also within normal values, averaging (186.943).
IR in upward trend: price rose above 50-day moving average on October 29, 2026
IR moved above its 50-day moving average on October 29, 2026 date and that indicates a change from a downward trend to an upward trend. In 22 of 30 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 73%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 29, 2026. You may want to consider a long position or call options on IR as a result. In 60 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 70%.
The Moving Average Convergence Divergence (MACD) for IR just turned positive on October 30, 2026. Looking at past instances where IR's MACD turned positive, the stock continued to rise in 37 of 52 cases over the following month. The odds of a continued upward trend are 71%.
The 10-day moving average for IR crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 71%.
Following a +6.10% 3-day Advance, the price is estimated to grow further. Considering data from situations where IR advanced for three days, in 212 of 322 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
IR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 188 of 269 cases where IR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 70%.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 59%.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. IR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 54 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock slightly better than average.
The Tickeron Valuation Rating of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.050) is normal, around the industry mean (4.242). P/E Ratio (32.926) is within average values for comparable stocks, (38.374). Projected Growth (PEG Ratio) (0.619) is also within normal values, averaging (1.879). Dividend Yield (0.001) settles around the average of (0.030) among similar stocks. P/S Ratio (3.547) is also within normal values, averaging (186.943).
The Tickeron SMR rating for this company is 73 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 88 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
EMR | IR | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 29 | 34 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 81 Overvalued | 65 Fair valued | |
PROFIT vs RISK RATING 1..100 | 18 | 54 | |
SMR RATING 1..100 | 62 | 73 | |
PRICE GROWTH RATING 1..100 | 16 | 50 | |
P/E GROWTH RATING 1..100 | 38 | 88 | |
SEASONALITY SCORE 1..100 | 14 | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
IR's Valuation (65) in the Industrial Conglomerates industry is in the same range as EMR (81) in the Electrical Products industry. This means that IR’s stock grew similarly to EMR’s over the last 12 months.
EMR's Profit vs Risk Rating (18) in the Electrical Products industry is somewhat better than the same rating for IR (54) in the Industrial Conglomerates industry. This means that EMR’s stock grew somewhat faster than IR’s over the last 12 months.
EMR's SMR Rating (62) in the Electrical Products industry is in the same range as IR (73) in the Industrial Conglomerates industry. This means that EMR’s stock grew similarly to IR’s over the last 12 months.
EMR's Price Growth Rating (16) in the Electrical Products industry is somewhat better than the same rating for IR (50) in the Industrial Conglomerates industry. This means that EMR’s stock grew somewhat faster than IR’s over the last 12 months.
EMR's P/E Growth Rating (38) in the Electrical Products industry is somewhat better than the same rating for IR (88) in the Industrial Conglomerates industry. This means that EMR’s stock grew somewhat faster than IR’s over the last 12 months.
| EMR | IR | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 40% | N/A |
| Stochastic ODDS (%) | 1 day ago 52% | 1 day ago 59% |
| Momentum ODDS (%) | 1 day ago 68% | 1 day ago 70% |
| MACD ODDS (%) | 1 day ago 68% | 1 day ago 71% |
| TrendWeek ODDS (%) | 1 day ago 61% | 1 day ago 68% |
| TrendMonth ODDS (%) | 1 day ago 56% | 1 day ago 65% |
| Advances ODDS (%) | 2 days ago 63% | 1 day ago 66% |
| Declines ODDS (%) | 11 days ago 56% | 8 days ago 59% |
| BollingerBands ODDS (%) | 1 day ago 55% | 1 day ago 73% |
| Aroon ODDS (%) | 1 day ago 55% | 1 day ago 70% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
EMR’s FA Score shows that 2 FA rating(s) are green while IR’s FA Score has 0 green FA rating(s).
- EMR’s FA Score: 2 green, 3 red.
- IR’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
EMR’s TA Score shows that 5 TA indicator(s) are bullish while IR’s TA Score has 7 bullish TA indicator(s).
- EMR’s TA Score: 5 bullish, 4 bearish.
- IR’s TA Score: 7 bullish, 2 bearish.
Price Growth
EMR (@Industrial Machinery) experienced а +2.07% price change this week, while IR (@Industrial Machinery) price change was +8.94% for the same time period.
The average weekly price growth across all stocks in the @Industrial Machinery industry was -0.31%. For the same industry, the average monthly price growth was -13.39%, and the average quarterly price growth was -19.07%.
Reported Earning Dates
EMR is expected to report earnings on Nov 04, 2026.
IR is expected to report earnings on Feb 18, 2027.
Industries' Descriptions
@Industrial Machinery (-0.31% weekly)The industry makes and maintains machines for consumers, the industry, and most other companies. While it has traditionally been categorized as heavy industry, some smaller companies are also branching into the light category. The industry is pivotal in providing the equipment for production in businesses like agriculture, mining, industry and construction, gas, electricity and water utilities. It also supplies supporting equipment for almost all sectors of the economy, such as equipment for heating, and air conditioning of buildings. Illinois Tool Works Inc., Parker-Hannifin Corporation and Rockwell Automation Inc are some of the major U.S. companies operating in this industry.
Advertisement